Publication | Open Access
The efficacy of paxlovid in elderly patients infected with SARS-CoV-2 omicron variants: Results of a non-randomized clinical trial
27
Citations
18
References
2022
Year
In Chinese elder patients infected with the variant of SARS-CoV-2 omicron, our data suggest that Paxlovid can significantly reduce the nucleic acid shedding time.
| Year | Citations | |
|---|---|---|
Page 1
Page 1